Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Value in Health Regional Issues is Scopus-indexed (Q2, CiteScore 3.3), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2212-1099Verify ISSN ↗2212-1102Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$2,400 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 18 / 57 | 69th | Q2 |
| Economics, Econometrics and Finance (miscellaneous) | 88 / 283 | 69th | Q2 |
| Health Policy | 153 / 330 | 53rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 3.3.
Value in Health Regional Issues is Q2 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 18 of 57), Q2 in Economics, Econometrics and Finance (miscellaneous) (rank 88 of 283) and Q2 in Health Policy (rank 153 of 330), by CiteScore 2025.
Value in Health Regional Issues is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.3, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.633, quartile Q1, with an H-index of 34.
The publisher lists an article processing charge of about US$2,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Value in Health Regional Issues is published by Elsevier Inc. Its print ISSN is 2212-1099 and its online ISSN is 2212-1102.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Value in Health Regional Issues has an h-index of 41 and a 2-year mean of 0.69 citations per paper (OpenAlex). Its Scopus CiteScore is 3.3, quartile Q2. On 2-year citations it ranks #33 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Value in Health Regional Issues published 369 papers in 2025; its busiest recent year was 2020 with 583. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from United States (9%), Thailand (8.5%) and Australia (7.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.